[Vasodilator therapy of pump failure in acute myocardial infarction].
D000328:Adult; D000368:Aged; D005260:Female; D005292:Ferricyanides / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D009599:Nitroprusside / Q000494:pharmacology / Q000627:therapeutic use*; D011224:Prazosin / Q000494:pharmacology / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D005292:Ferricyanides; D011799:Quinazolines; D014665:Vasodilator Agents; D009599:Nitroprusside; D007548:Isosorbide Dinitrate; D011224:Prazosin
Tratamiento con vasodilatadores de la falla de bomba en el infarto agudo de miocardio.